ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Feb 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
January 2026
Latest News
Fusion energy: Progress, partnerships, and the path to deployment
Over the past decade, fusion energy has moved decisively from scientific aspiration toward a credible pathway to a new energy technology. Thanks to long-term federal support, we have significantly advanced our fundamental understanding of plasma physics—the behavior of the superheated gases at the heart of fusion devices. This knowledge will enable the creation and control of fusion fuel under conditions required for future power plants. Our progress is exemplified by breakthroughs at the National Ignition Facility and the Joint European Torus.
R. Durrer, T.A. Parish, G. Schlapper, R. Carrera
Fusion Science and Technology | Volume 19 | Number 3 | May 1991 | Pages 1337-1341
Result of Large Experiment and Plasma Engineering | doi.org/10.13182/FST91-A29528
Articles are hosted by Taylor and Francis Online.
The IGNITEX experiment is being designed to study the physics of ignited plasmas. Over the service lifetime of the device (two years), it is expected to be pulsed 2,000 times with each pulse producing 150 MW of DT fusion power for approximately five seconds. Neutrons from each pulse will activate the magnet structure, liquid nitrogen in the cryostat and test cell air. Radioactive effluents from IGNITEX will primarily result from activated air, activated liquid nitrogen, and tritium. To provide a perspective for evaluating the doses resulting from the gaseous effluents from IGNITEX, the doses from the gaseous effluents from a 1 MW fission research reactor were also calculated.For both facilities, the primary effluents are airborne. Two dose receptor locations were assumed. The first was taken to be the building nearest to the facility and it was taken to be 400 m distant. The second was the nearest residence and it was taken to be 1.2 km distant. For the dose calculations, the air stability was assumed to be neutral and the dose receptors were assumed to be in the direction of a 4.5 m/sec prevailing wind. All releases were taken to be at ground level. The equations used to calculate the annual doses were taken from Regulatory Guide 1.109. The gaseous effluents from IGNITEX were assumed to consist of 41Ar, 13N, 16N, 14C, and 3H. Effluents from the fission research reactor consisted of 41Ar, gaseous and semi-volatile fission products. Each facility's dose was compared to the 10CFR50 Appendix I limits. In each dose category, with the exception of the thyroid dose the dose resulting from the operation of IGNITEX were more than that of the fission reactor. The increased doses were due primarily to the activated nitrogen releases.